Detalhe da pesquisa
1.
Estimation of radiation dosimetry for 68Ga-HBED-CC (PSMA-11) in patients with suspected recurrence of prostate cancer.
Nucl Med Biol
; 46: 32-35, 2017 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-28012435
2.
Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist.
J Neurosurg
; 126(2): 446-459, 2017 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-27177180
3.
Whole-body PET/CT evaluation of tumor perfusion using generator-based 62Cu-ethylglyoxal bis(thiosemicarbazonato)copper(II): validation by direct comparison to 15O-water in metastatic renal cell carcinoma.
J Nucl Med
; 56(1): 56-62, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25525184
4.
Serdemetan antagonizes the Mdm2-HIF1α axis leading to decreased levels of glycolytic enzymes.
PLoS One
; 8(9): e74741, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-24040331
5.
TGF-beta1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer.
J Clin Invest
; 120(1): 290-302, 2010 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-19955655
6.
PTEN and p53 are required for hypoxia induced expression of maspin in glioblastoma cells.
Cell Cycle
; 8(6): 896-901, 2009 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-19221500
7.
Therapeutic considerations for Mdm2: not just a one trick pony.
Expert Opin Drug Discov
; 3(11): 1309-1321, 2008 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-19738896